Citadel Advisors
VXRT

Citadel Advisors’s Vaxart VXRT Stock Holding History

Citadel Advisors’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-501,623
Closed -$322K – 15675
2024
Q4 		$332K Buy
+501,623
New +$348K ﹤0.01% 9443
2024
Q2 		– Sell
-769,467
Closed -$639K – 15519
2024
Q1 		$1M Buy
769,467
+270,449
+54% +$283K ﹤0.01% 6912
2023
Q4 		$286K Buy
499,018
+494,026
+9,896% +$341K ﹤0.01% 9268
2023
Q3 		$3.76K Sell
4,992
-744,692
-99% -$566K ﹤0.01% 13551
2023
Q2 		$547K Buy
749,684
+270,134
+56% +$251K ﹤0.01% 7750
2023
Q1 		$363K Sell
479,550
-1,960,812
-80% -$1.82M ﹤0.01% 8982
2022
Q4 		$2.34M Buy
2,440,362
+998,306
+69% +$1.41M ﹤0.01% 5184
2022
Q3 		$3.14M Buy
1,442,056
+599,421
+71% +$2.07M ﹤0.01% 4722
2022
Q2 		$2.95M Buy
842,635
+710,626
+538% +$2.65M ﹤0.01% 4786
2022
Q1 		$665K Sell
132,009
-26,191
-17% -$133K ﹤0.01% 8700
2021
Q4 		$992K Buy
158,200
+47,227
+43% +$322K ﹤0.01% 7980
2021
Q3 		$882K Buy
+110,973
New +$913K ﹤0.01% 8466
2021
Q2 		– Sell
-498,283
Closed -$3.48M – 14523
2021
Q1 		$3.02M Buy
498,283
+424,791
+578% +$3.27M ﹤0.01% 5441
2020
Q4 		$420K Sell
73,492
-146,687
-67% -$933K ﹤0.01% 8464
2020
Q3 		$1.46M Sell
220,179
-2,876,785
-93% -$25.6M ﹤0.01% 5318
2020
Q2 		$27.4M Buy
+3,096,964
New +$8.9M 0.01% 1228
2019
Q4 		– Sell
-86,221
Closed -$31K – 9843
2019
Q3 		$31K Buy
+86,221
New +$56.3K ﹤0.01% 8844
2018
Q4 		– Sell
-12,683
Closed -$36K – 9825
2018
Q3 		$36K Buy
+12,683
New +$38.6K ﹤0.01% 8882
2018
Q1 		– Sell
-4,775
Closed -$30K – 8844
2017
Q4 		$30K Buy
4,775
+2,616
+121% +$18.3K ﹤0.01% 7768
2017
Q3 		$16K Buy
+2,159
New +$14.7K ﹤0.01% 7398
2017
Q1 		– Sell
-1,278
Closed -$17K – 8104
2016
Q4 		$17K Buy
+1,278
New +$19.5K ﹤0.01% 7114
2016
Q2 		– Sell
-1,218
Closed -$20K – 7471
2016
Q1 		$20K Buy
+1,218
New +$21.7K ﹤0.01% 6462
2014
Q2 		– Sell
-6,523
Closed -$438K – 8340
2014
Q1 		$438K Buy
+6,523
New +$403K ﹤0.01% 4533

Other funds holding VXRT

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HSA
HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
CFO
Custos Family Office Austin, Texas $147M AUM 17.83% 1-Year Est. Return
LCM
LVM Capital Management Portage, Michigan $1.19B AUM 41.5% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Citadel Advisors's VXRT Position: Q1 2025 in Review

Citadel Advisors sold out of Vaxart (VXRT) in Q1 2025, closing a stake of 501,623 shares — an estimated $322K sold.

Citadel Advisors first reported a position in VXRT in Q1 2014 and held it in 23 quarters. The position peaked at $27.4M in Q2 2020. 92 funds tracked by Wall St. Rank hold VXRT as of Q1 2025.

  • Citadel Advisors reported no remaining Vaxart position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 501,623 Vaxart shares in Q1 2025, an estimated $322K.
  • Citadel Advisors first reported a position in Vaxart in Q1 2014 and held it in 23 quarters.
  • Citadel Advisors's Vaxart position peaked at $27.4M in Q2 2020.
  • 92 funds tracked by Wall St. Rank held Vaxart as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.